FDA clears Teva's copy of asthma medicine by AstraZeneca

11/20/2008 | Google

The FDA is allowing Teva Pharmaceutical Industries to market its version of AstraZeneca's Pulmicort Respules, an asthma drug for children. AstraZeneca filed a patent-infringement suit against Teva over the product, and a court hearing is scheduled for Jan. 12.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Health Services Researcher
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO